Image-guided interventional surgery firm Stereotaxis of St. Louis said that its magnetically enabled 8-mm ablation catheter has received U.S. Food and Drug Administration (FDA) clearance and will soon be commercially available in the U.S.
The 8-mm catheter expands electrophysiology applications for the company's magnetic navigation system by providing physicians the capability to deliver ablations for treating atrial arrhythmias, according to Stereotaxis.
Stereotaxis reported that successful European cases with the device have been completed at San Raffaele University Hospital in Milan, Italy, and the Hanseatic Heart Center/St. Georg in Hamburg, Germany.
By AuntMinnie.com staff writers
April 3, 2007
Related Reading
Stereotaxis hits procedure milestone, January 25, 2007
Stereotaxis shows Q3 revenue gain, November 10, 2006
Stereotaxis, Medtronic partner for clinical study, May 18, 2006
Stereotaxis, Siemens extend partnership, May 17, 2006
Stereotaxis completes proof-of-concept demo, May 16, 2006
Copyright © 2007 AuntMinnie.com
